AISP vs ASML

AISP exhibits severe financial health concerns, with a Piotroski F-Score of 2/9 indicating high distress risk and no Altman Z-Score available, which raises red flags for potential bankruptcy. Despite strong revenue growth of 102.5% YoY and a high gross margin of 50.24%, the company reports a negative operating margin (-9.44%) and ROA of -27.18%, signaling poor operational efficiency. The stock trades at a P/E of 3.46 but has a forward P/E of 17.53, suggesting overvaluation relative to future earnings expectations. Analysts have only one coverage, with a target price of $8.00, but the company has consistently missed earnings estimates, with an average surprise of -358% over the last four quarters.

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.